CXCL10 and Hepatic fibrosis: Consequently, the correct monitoring and adequate selection of the best candidates for standard or future triple therapy (including protease inhibitors) in this increasing population of HIV-HCV co-infected patients, is of outmost importance (24).An important finding of the current study is the correlation between the plasma level of IP-10 and the degree of liver fibrosis in HIV-HCV co-infected patients.